Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
210 hedge funds and large institutions have $2.87B invested in Abiomed Inc in 2015 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 65 increasing their positions, 64 reducing their positions, and 13 closing their positions.
415% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 13
78% more capital invested
Capital invested by funds: $1.61B → $2.87B (+$1.26B)
33% more funds holding
Funds holding: 158 → 210 (+52)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
2% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 64
15% less call options, than puts
Call options by funds: $4.65M | Put options by funds: $5.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.5M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$22.7M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$11.1M |
| 4 |
Renaissance Technologies
New York
|
+$10.2M |
| 5 |
Bank of New York Mellon
New York
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$61.3M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$45.6M |
| 3 |
Millennium Management
New York
|
-$43.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$30.6M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$26.3M |
ABMD Hedge Fund Activity: Q1 2015 in Review
210 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2015, worth a combined $2.87B — up 78% from $1.61B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new ABMD positions and 13 closed out — a net gain of 54 holders — while 65 added to existing stakes and 64 trimmed.
The largest buyer was Vanguard Group, adding an estimated $24.5M. The largest seller was Jackson Square Partners, cutting an estimated $61.3M.
- 210 institutional investors held Abiomed Inc (ABMD) as of Q1 2015, up from 158 in Q4 2014.
- Funds reported $2.87B of Abiomed Inc stock for Q1 2015, up 78% quarter-over-quarter.
- 67 funds opened new Abiomed Inc positions in Q1 2015 and 13 closed out, a net change of +54 holders.
- The largest Abiomed Inc buyer in Q1 2015 was Vanguard Group, an estimated $24.5M added.
- The largest Abiomed Inc seller in Q1 2015 was Jackson Square Partners, an estimated $61.3M sold.
Based on aggregated 13F filings for Q1 2015.